SCHEMBL140457

SCHEMBL140457

O=S(=O)(NCc1ccccc1Cl)C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
ALDH1A1 P00352 2/20 0.49
POLB P06746 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
TP53 P04637 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPK1 P28482 1/20 0.46
KCNJ5 P48544 1/20 0.46
KCNJ3 P48549 1/20 0.46
CA2 P00918 1/20 0.45
LMNA P02545 2/20 0.43
MAPT P10636 1/20 0.43
CHRM2 P08172 1/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL141242 0.84 PTGS1 (0.58) PTGS1PTGS2ALDH1A1POLBHPGD
SCHEMBL30728407 0.81 CNR1 (0.44) PTGS1PTGS2ALDH1A1KMT2ATP53
SCHEMBL138368 0.81 LMNA (0.68) PTGS1PTGS2POLBKMT2AL3MBTL1
SCHEMBL140452 0.79 MEN1 (0.55) PTGS1PTGS2ALDH1A1HPGDKMT2A
SCHEMBL139590 0.79 HPGD (0.51) PTGS1PTGS2HPGDKMT2AL3MBTL1
SCHEMBL138377 0.79 NPSR1 (0.46) ALDH1A1HPGDKMT2ACA2LMNA
SCHEMBL17201441 0.77 CA2 (0.55) CA2LMNA
SCHEMBL20906520 0.77 CA2 (0.64) HPGDKMT2AMAPK1CA2LMNA
SCHEMBL15836453 0.76 CA2 (0.42) PTGS1PTGS2ALDH1A1POLBKMT2A
SCHEMBL138372 0.76 KDM4E (0.61) ALDH1A1POLBKMT2ATP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059179-A1 PALLADIUM-CATALYZED ORTHO-FLUORINATION The Scripps Research Insitiute (US) 2012-03-08 US disclosed
WO-2010115098-A2 PALLADIUM-CATALYZED ORTHO-FLUORINATION THE SCRIPPS RESEARCH INSTITUTE (US) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059179-A1 PALLADIUM-CATALYZED ORTHO-FLUORINATION POF1B, OCIAD2, ODC1 PTGS1 4856/4885PTGS2 4566/4885ALDH1A1 3393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.